indirect update:
" Successful first administration of Myrcludex B, a first-in-class Hepatitis B and D Virus entry inhibitor, in humans " - this is the title for a presentation that will came in AASLD in November (no other info available at this moment)
I know we desperately need something.
All these companies take for ever their pipe line of new drug testing..
Thanks. Something to look forward for the results
if it is promising .. booking ticket to moscow .. to join one group of trials ..
Funds are provided in part by the government there so there will be control over quality and accessibility to the medicine for people that need it.
I really hope they succeed.